Dr. Emerencienne D. Yonga, MD

Dr. Yonga practices at Winchester Medical Center in Winchester, Virginia, part of Valley Health.

Dr. Yonga's NPI, 1205093705, was assigned on May 21, 2008. Dr. Yonga holds Virginia license 0101243788.

Dr. Yonga's primary practice is Winchester Medical Center, at 1840 Amherst St, Winchester, VA 22601 in Winchester City. The practice phone is (540) 536-8000.

Dr. Yonga's primary practice is Winchester Medical Center in Winchester, Virginia, part of Valley Health. Dr. Yonga is also affiliated with Inova Alexandria Hospital. The medical group on file is Emergency Medicine Physicians (EMP). Dmand AI also links Dr. Yonga to 5 more hospitals, 4 medical groups, 1 physician office and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yonga practices, 9 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Yonga's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Yonga's licenses on file in 2 states: Virginia and North Carolina.

CMS data shows 841 Medicare services from Dr. Yonga across 6 procedure codes in 2024, for 550 Medicare patients. Medicare paid $72,874 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 550 Medicare patients who saw Dr. Yonga in 2024. The largest group is 75 to 84, with 212 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yonga's median patient age at 68, with 54% women.

In 2024, Dr. Yonga wrote 469 Medicare Part D claims for 152 patients. 87% of them were for generic drugs. CMS names the drug for 182 of them, across 12 drugs with 11 or more claims each, at $9,440 in total drug cost. In 2023, CMS named 229 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Yonga for performance year 2024, reported as part of a group. Dr. Yonga accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 82 general payments to Dr. Yonga from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $419.